These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Characterization of daytime sleepiness and psychomotor performance following H1 receptor antagonists. Witek TJ, Canestrari DA, Miller RD, Yang JY, Riker DK. Ann Allergy Asthma Immunol; 1995 May; 74(5):419-26. PubMed ID: 7749974 [Abstract] [Full Text] [Related]
6. Central effects of fexofenadine and cetirizine: measurement of psychomotor performance, subjective sleepiness, and brain histamine H1-receptor occupancy using 11C-doxepin positron emission tomography. Tashiro M, Sakurada Y, Iwabuchi K, Mochizuki H, Kato M, Aoki M, Funaki Y, Itoh M, Iwata R, Wong DF, Yanai K. J Clin Pharmacol; 2004 Aug; 44(8):890-900. PubMed ID: 15286093 [Abstract] [Full Text] [Related]
8. Psychomotor performance in healthy young adult volunteers receiving lormetazepam and placebo: a single-dose, randomized, double-blind, crossover trial. Fabbrini M, Frittelli C, Bonanni E, Maestri M, Manca ML, Iudice A. Clin Ther; 2005 Jan; 27(1):78-83. PubMed ID: 15763608 [Abstract] [Full Text] [Related]
9. Central effects of the H1-antihistamine, cetirizine. Nicholson AN, Turner C. Aviat Space Environ Med; 1998 Feb; 69(2):166-71. PubMed ID: 9491258 [Abstract] [Full Text] [Related]
10. Quantitative effects of cetirizine and diphenhydramine on mental performance measured using an automobile driving simulator. Gengo FM, Gabos C, Mechtler L. Ann Allergy; 1990 Jun; 64(6):520-6. PubMed ID: 1971741 [Abstract] [Full Text] [Related]
11. Comparison of peripheral and central effects of single and repeated oral dose administrations of bilastine, a new H1 antihistamine: a dose-range study in healthy volunteers with hydroxyzine and placebo as control treatments. García-Gea C, Martínez-Colomer J, Antonijoan RM, Valiente R, Barbanoj MJ. J Clin Psychopharmacol; 2008 Dec; 28(6):675-85. PubMed ID: 19011437 [Abstract] [Full Text] [Related]
12. The impact of extended sleep on daytime alertness, vigilance, and mood. Kamdar BB, Kaplan KA, Kezirian EJ, Dement WC. Sleep Med; 2004 Sep; 5(5):441-8. PubMed ID: 15341888 [Abstract] [Full Text] [Related]
16. Nighttime versus daytime hypnotic self-administration. Roehrs T, Bonahoom A, Pedrosi B, Zorick F, Roth T. Psychopharmacology (Berl); 2002 May; 161(2):137-42. PubMed ID: 11981593 [Abstract] [Full Text] [Related]
17. Maintaining alertness and performance during sleep deprivation: modafinil versus caffeine. Wesensten NJ, Belenky G, Kautz MA, Thorne DR, Reichardt RM, Balkin TJ. Psychopharmacology (Berl); 2002 Jan; 159(3):238-47. PubMed ID: 11862356 [Abstract] [Full Text] [Related]
18. Lack of effects between rupatadine 10 mg and placebo on actual driving performance of healthy volunteers. Vuurman E, Theunissen E, van Oers A, van Leeuwen C, Jolles J. Hum Psychopharmacol; 2007 Jul; 22(5):289-97. PubMed ID: 17599335 [Abstract] [Full Text] [Related]
19. Central effects of cinnarizine: restricted use in aircrew. Nicholson AN, Stone BM, Turner C, Mills SL. Aviat Space Environ Med; 2002 Jun; 73(6):570-4. PubMed ID: 12056673 [Abstract] [Full Text] [Related]
20. Effects of bepotastine, cetirizine, fexofenadine, and olopatadine on histamine-induced wheal-and flare-response, sedation, and psychomotor performance. Takahashi H, Ishida-Yamamoto A, Iizuka H. Clin Exp Dermatol; 2004 Sep; 29(5):526-32. PubMed ID: 15347340 [Abstract] [Full Text] [Related] Page: [Next] [New Search]